IL1R2 and pancreatic neoplasm: IL‐1R2, an IL‐1 decoy receptor, is overexpressed in various cancers (tissues and/or serum), including breast, gastric, and pancreatic cancers, and is linked to a poor prognosis [26, 27, 28].